$PLAO
Patria Latin American Opportunity Acquisition Corp. Stock $plao

$plao Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023024920 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$173.2K	$901.7K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$173.2K	$901.7K
YoY Change	247.22%	1708.16%
Operating Profit		-$901.7K
YoY Change
Interest Expense	$4.349M	$10.47M
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$662.2K
YoY Change
Pretax Income	$4.175M	$9.256M
YoY Change	-8472.51%	-18660.76%
Income Tax
% Of Pretax Income
Net Earnings	$4.175M	$9.256M
YoY Change	-8472.51%	-18660.75%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.15	$0.38
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$241.0M	$241.0M
YoY Change		54777113.64%
Cash & Equivalents	$707.7K
Short-Term Investments	$240.3M	$240.3M
Other Short-Term Assets	$307.8K	$307.8K
YoY Change		-51.82%
Inventory
Prepaid Expenses	$307.8K
Receivables
Other Receivables
Total Short-Term Assets	$241.3M	$241.3M
YoY Change	37656.44%	37656.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$241.3M	$241.3M
Total Long-Term Assets	$0.00	$0.00
Total Assets	$241.3M	$241.3M
YoY Change	37656.44%	37656.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$68.63K	$68.63K
YoY Change	-69.7%	-69.7%
Deferred Revenue
YoY Change
Short-Term Debt	$3.140K	$3.140K
YoY Change		-99.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.46M	$10.46M
YoY Change	1475.48%	1475.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.46M	$10.46M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$10.46M	$10.46M
YoY Change	1475.48%	1475.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.447M
YoY Change	18843.69%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.446M	$230.9M
YoY Change
Total Liabilities & Shareholders Equity	$241.3M	$241.3M
YoY Change	37656.44%	37656.39%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$4.175M	$9.256M
YoY Change	-8472.51%	-18660.75%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$98.81K	-$1.156M
YoY Change	-22556.82%	-262884.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$236.9M
YoY Change
Cash From Investing Activities	$0.00	-$236.9M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$230.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$238.8M
YoY Change
NET CHANGE
Cash From Operating Activities	-98.81K	-$1.156M
Cash From Investing Activities	0.000	-$236.9M
Cash From Financing Activities	0.000	$238.8M
Net Change In Cash	-98.81K	$707.3K
YoY Change	-22556.82%	160652.05%
FREE CASH FLOW
Cash From Operating Activities	-$98.81K	-$1.156M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41321
CY2022	dei	Entity Registrant Name EntityRegistrantName	PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	18 Forum Lane
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd floor, Camana Bay, PO Box 757
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-9006
CY2022	dei	City Area Code CityAreaCode	1 345
CY2022	dei	Local Phone Number LocalPhoneNumber	640 4900
CY2022	dei	Security12b Title Security12bTitle	Class A ordinary shares, included as part of the units
CY2022	dei	Trading Symbol TradingSymbol	PLAO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	707749	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	440	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	307756	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	240311986	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	241327491	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	440	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	638729	usd
CY2022Q4	us-gaap	Assets Assets	241327491	usd
CY2021Q4	us-gaap	Assets Assets	639169	usd
CY2022Q4	plao	Due To Related Party DueToRelatedParty	3144	usd
CY2021Q4	plao	Due To Related Party DueToRelatedParty	437508	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8050000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2340000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	68627	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	226529	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10461771	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	664037	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10461771	usd
CY2021Q4	us-gaap	Liabilities Liabilities	664037	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	240311986	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	plao	Common Stock Value One CommonStockValueOne	575	usd
CY2021Q4	plao	Common Stock Value One CommonStockValueOne	575	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24425	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9446841	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49868	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9446266	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24868	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	241327491	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	639169	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	49308	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	901733	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	560	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-901733	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-49868	usd
CY2022	plao	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	-7060500	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3411986	usd
CY2022	plao	Deferred Underwriting Fees Payable DeferredUnderwritingFeesPayable	8050000	usd
CY2022	plao	Transaction Costs Allocation To Derivative Warrant Liabilities TransactionCostsAllocationToDerivativeWarrantLiabilities	314508	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
	us-gaap	Net Income Loss NetIncomeLoss	-49868	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24868	usd
CY2022	plao	Stock Issued During Period Value Excess Cash Received Over Fair Value Of Private Placement Warrants StockIssuedDuringPeriodValueExcessCashReceivedOverFairValueOfPrivatePlacementWarrants	9251000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	27928643	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9446266	usd
	plao	Stock Issued During Period Value Ordinary Shares To Sponsor StockIssuedDuringPeriodValueOrdinarySharesToSponsor	25000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-49868	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24868	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
	us-gaap	Net Income Loss NetIncomeLoss	-49868	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3411986	usd
CY2022	plao	Transaction Costs Allocated To Derivative Warrant Liabilities TransactionCostsAllocatedToDerivativeWarrantLiabilities	314508	usd
	plao	Formation And Operating Expenses Funded By Note Payable Through Sponsor FormationAndOperatingExpensesFundedByNotePayableThroughSponsor	2527	usd
CY2022	plao	Change In Fair Value Of Derivatives Warrant Liabilities ChangeInFairValueOfDerivativesWarrantLiabilities	-7060.5	usd
	plao	Formation Expenses FormationExpenses	19308	usd
CY2022	plao	Offering Costs Paid Promissory Note Related Party OfferingCostsPaidPromissoryNoteRelatedParty	307756	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	53239	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	28473	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156250	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	440	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	715209000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	715209000	usd
CY2022	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	236900000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-236900000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	437507	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-147190	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	230000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	14500000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5151744	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	238763559	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	707309	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	440	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	440	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	707749	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	440	usd
CY2022	plao	Initial Shares Subject To Possible Redemption InitialSharesSubjectToPossibleRedemption	212383343	usd
CY2022	plao	Immediate Accretion Of Shares To Redemption Value ImmediateAccretionOfSharesToRedemptionValue	24516657	usd
CY2022	plao	Accretion Of Shares To Redemption Value AccretionOfSharesToRedemptionValue	3411986	usd
CY2022	plao	Offering And Formation Costs Paid For By A Related Party OfferingAndFormationCostsPaidForByARelatedParty	150334000000	usd
CY2022	plao	Offering Costs Included In Accrued Expenses OfferingCostsIncludedInAccruedExpenses	211141	usd
	plao	Offering Costs Included In Accrued Expenses OfferingCostsIncludedInAccruedExpenses	198056	usd
	plao	Offering Costs Paid Prepaid Legal Expense Funded By Sponsor OfferingCostsPaidPrepaidLegalExpenseFundedBySponsor	5692	usd
CY2022	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	13779665	usd
CY2022	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	8050000	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	4600000	usd
CY2022Q4	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	1129665	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	314508	usd
CY2022	plao	Charged To Temporary Equity ChargedToTemporaryEquity	13456157	usd
CY2022	plao	Gross Proceeds GrossProceeds	230000000	usd
CY2022	plao	Trust Account Description TrustAccountDescription	Except with respect to earnings on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of the Class A Ordinary Shares included in the Units (the “Public Shares”) if the Company is unable to complete the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus); or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the Initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses.
CY2022	plao	Fair Market Value Rate FairMarketValueRate	0.80	pure
CY2022Q4	plao	Sale Of Price Per Unit SaleOfPricePerUnit	10.3
CY2022	plao	Aggregate Percent AggregatePercent	0.15	pure
CY2022Q4	plao	Public Shares Redeem Percentage PublicSharesRedeemPercentage	1	pure
CY2022	plao	Interest To Pay Dissolution Expense InterestToPayDissolutionExpense	100000	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	10.3
CY2022	plao	Price Per Unit PricePerUnit	10.3
CY2022	plao	Net Proceeds Sale Of Units NetProceedsSaleOfUnits	236900000	usd
CY2022	plao	Working Capital WorkingCapital	943734	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	707749	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">Use of Estimates</p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p>
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	9275425	usd
CY2022Q4	plao	Accumulated Deficit AccumulatedDeficit	18653218	usd
CY2022Q4	us-gaap	Temporary Equity Share Subscriptions TemporaryEquityShareSubscriptions	23000000	shares
CY2022	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	9256245	usd
	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-49868	usd
CY2022	plao	Accretion Of Temporary Equity Excess Of Fair Value AccretionOfTemporaryEquityExcessOfFairValue	-27928643	usd
CY2022	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	18672398	usd
	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	49868	usd
CY2022Q4	us-gaap	Share Price SharePrice	10
CY2022	us-gaap	Accretion Expense AccretionExpense	27928643	usd
CY2022	plao	Class A Ordinary Shares Issuance Costs ClassAOrdinarySharesIssuanceCosts	-13465157	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-4151500	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	27928643	usd
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	240311986	usd
CY2022	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">Derivative Financial Instruments</p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">Concentration of Credit Risk</p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p>
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2022	plao	Sponsor Agreed To Purchase SponsorAgreedToPurchase	14500000	shares
CY2021Q1	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	25000	usd
CY2021Q1	plao	Aggregate Ordinary Shares AggregateOrdinaryShares	7187500	shares
CY2022Q1	plao	Founder Shares FounderShares	1437500	shares
CY2022Q1	plao	Founder Shares FounderShares	30000	shares
CY2022	plao	Underwriters Shares UnderwritersShares	90000	shares
CY2022	plao	Granted Shares GrantedShares	90000	shares
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	662245	usd
CY2022	plao	Stock Issued During Period Per Shares StockIssuedDuringPeriodPerShares	7.36
CY2022	us-gaap	Other Expenses OtherExpenses	662245	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	750000	shares
CY2022	plao	Ordinary Shares Per Shares OrdinarySharesPerShares	12
CY2022Q4	us-gaap	Percentage Of Debt Hedged By Interest Rate Derivatives PercentageOfDebtHedgedByInterestRateDerivatives	0.20	pure
CY2022Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	250000	usd
CY2022Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Fee DebtInstrumentUnusedBorrowingCapacityFee	250000	usd
CY2022Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	500000	usd
CY2021Q4	plao	Promissory Note PromissoryNote	437508	usd
CY2022Q4	plao	Due To Related Parties DueToRelatedParties	3144	usd
CY2022Q4	us-gaap	Securities Borrowed SecuritiesBorrowed	150334	usd
CY2022	us-gaap	Sponsor Fees SponsorFees	3144	usd
CY2022	plao	Office Space OfficeSpace	10000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	95484	usd
CY2022	plao	Working Capital Loans WorkingCapitalLoans	2000000	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1
CY2022	plao	Underwriting Discount Per Share UnderwritingDiscountPerShare	0.2
CY2022	us-gaap	Investment Company Payment By Affiliate Per Share InvestmentCompanyPaymentByAffiliatePerShare	0.35
CY2022	plao	Redemption Warrant Price Per Share RedemptionWarrantPricePerShare	10
CY2022	plao	Business Combination Description BusinessCombinationDescription	The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	plao	Founder Shares FounderShares	1437500	shares
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	240311986	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	240311986	usd
CY2022Q4	plao	Public Warrant PublicWarrant	1035000	usd
CY2022Q4	plao	Private Placement Warrants PrivatePlacementWarrants	1305000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	2340000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7060500	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.5
CY2022	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	9.82
CY2022	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	10.06
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.054	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.046	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y18D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0213	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0241	pure
CY2022	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	9400500	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	7060500	usd
CY2022Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	2340000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2021Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	plao	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
	plao	Transaction Costs Allocation To Derivative Warrant Liabilities TransactionCostsAllocationToDerivativeWarrantLiabilities		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	plao	Transaction Costs Allocated To Derivative Warrant Liabilities TransactionCostsAllocatedToDerivativeWarrantLiabilities		usd
CY2022	plao	Formation And Operating Expenses Funded By Note Payable Through Sponsor FormationAndOperatingExpensesFundedByNotePayableThroughSponsor		usd
	plao	Change In Fair Value Of Derivatives Warrant Liabilities ChangeInFairValueOfDerivativesWarrantLiabilities		usd
CY2022	plao	Formation Expenses FormationExpenses		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	plao	Initial Shares Subject To Possible Redemption InitialSharesSubjectToPossibleRedemption		usd
	plao	Immediate Accretion Of Shares To Redemption Value ImmediateAccretionOfSharesToRedemptionValue		usd
	plao	Accretion Of Shares To Redemption Value AccretionOfSharesToRedemptionValue		usd
CY2022	plao	Offering Costs Paid Prepaid Legal Expense Funded By Sponsor OfferingCostsPaidPrepaidLegalExpenseFundedBySponsor		usd
	plao	Deferred Underwriting Fees Payable DeferredUnderwritingFeesPayable		usd
	plao	Accretion Of Temporary Equity Excess Of Fair Value AccretionOfTemporaryEquityExcessOfFairValue		usd
CY2021Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001849737
CY2022Q2	dei	Entity Public Float EntityPublicFloat	0	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
plao-20221231_cal.xml	Edgar Link	unprocessable
0001213900-23-024920-index-headers.html	Edgar Link	pending
0001213900-23-024920-index.html	Edgar Link	pending
0001213900-23-024920.txt	Edgar Link	pending
0001213900-23-024920-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_patrialatin.htm	Edgar Link	pending
f10k2022ex31-2_patrialatin.htm	Edgar Link	pending
f10k2022ex32-1_patrialatin.htm	Edgar Link	pending
f10k2022ex32-2_patrialatin.htm	Edgar Link	pending
f10k2022ex4-1_patrialatin.htm	Edgar Link	pending
f10k2022_patrialatin.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plao-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
plao-20221231_def.xml	Edgar Link	unprocessable
plao-20221231_lab.xml	Edgar Link	unprocessable
plao-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_patrialatin_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLAO
Patria Latin American Opportunity Acquisition Corp. Stock $plao

2022 Q4 Form 10-K Financial Statement

#000121390023024920 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLAO Patria Latin American Opportunity Acquisition Corp. Stock $plao

2022 Q4 Form 10-K Financial Statement

#000121390023024920 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLAO
Patria Latin American Opportunity Acquisition Corp. Stock $plao